These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 8200278

  • 1. [Specific cytotoxicity of recombinant interleukin 6-pseudomonas exotoxin fusion protein (IL6-PE40) on LT12 leukemic cells expressing high levels of interleukin 6 receptor (IL6R)].
    Xi YZ.
    Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):419-22. PubMed ID: 8200278
    [Abstract] [Full Text] [Related]

  • 2. [Molecular design and construction of IL6D24-PE40KDEL, a novel recombinant interleukin6-pseudomonas exotoxin fusion protein, having targeted cytotoxicity for leukemias expressing interleukin6 receptors].
    Zheng LY, Xi YZ, Kong FH, Cui JW, Liang F, Liu N, Sun YY, Guo SQ.
    Zhonghua Yi Xue Za Zhi; 2003 Jul 25; 83(14):1246-50. PubMed ID: 12930640
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.
    Joshi BH, Leland P, Puri RK.
    Croat Med J; 2003 Aug 25; 44(4):455-62. PubMed ID: 12950150
    [Abstract] [Full Text] [Related]

  • 13. Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells.
    Liu TF, Willingham MC, Tatter SB, Cohen KA, Lowe AC, Thorburn A, Frankel AE.
    Bioconjug Chem; 2003 Aug 25; 14(6):1107-14. PubMed ID: 14624623
    [Abstract] [Full Text] [Related]

  • 14. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
    Kioi M, Kawakami K, Puri RK.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6231-8. PubMed ID: 15448012
    [Abstract] [Full Text] [Related]

  • 15. Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variants.
    Braakman E, Vogels R, Martens AC, Vermeulen J, Bron M, Hoogerbrugge PM, Valerio D, Hagenbeek A.
    Gene Ther; 1999 Jun 15; 6(6):1139-46. PubMed ID: 10455417
    [Abstract] [Full Text] [Related]

  • 16. [Biochemical and physical properties for a recombinant IL6 Pseudomonas exotoxin fusion protein IL6D24-PE40KDEL].
    Cui JW, Guo SQ, Sun YY, Liu N, Liang F, Xi YZ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec 15; 12(6):825-8. PubMed ID: 15631670
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.
    Siegall CB, Chaudhary VK, FitzGerald DJ, Pastan I.
    Proc Natl Acad Sci U S A; 1988 Dec 15; 85(24):9738-42. PubMed ID: 3264406
    [Abstract] [Full Text] [Related]

  • 18. Potent receptor-mediated cytotoxicity of granulocyte colony-stimulating factor-Pseudomonas exotoxin, a fusion protein against myeloid leukemia cells.
    Oshima Y, Tojo A, Fujimura A, Niho Y, Asano S.
    Biochem Biophys Res Commun; 2004 Jun 25; 319(2):582-9. PubMed ID: 15178446
    [Abstract] [Full Text] [Related]

  • 19. The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells.
    Ozbek S, Peters M, Breuhahn K, Mann A, Blessing M, Fischer M, Schirmacher P, Mackiewicz A, Rose-John S.
    Oncogene; 2001 Feb 22; 20(8):972-9. PubMed ID: 11314032
    [Abstract] [Full Text] [Related]

  • 20. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
    Yang D, Kuan CT, Payne J, Kihara A, Murray A, Wang LM, Alimandi M, Pierce JH, Pastan I, Lippman ME.
    Clin Cancer Res; 1998 Apr 22; 4(4):993-1004. PubMed ID: 9563895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.